Petient who has Iron deficiency anemia in gynecologic malignancy disease Iron deficiency anemia, iv iron, gynecologic malignancy disease
Conditions
Interventions
The patient who recieved intravenous iron supplement for treatment iron deficiency anemia during chemotherapy course.,The patient who recieved standard treatment (oral iron supplement or blood transfu
Treatment,Treatment
Intervention group,Intervention group
Sponsors
Faculty of Medicine, KhonKaen university
Eligibility
Sex/Gender
Female
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Patient who diagnosed with gynecologic-oncology disease recieving chemotherapy between 01/01/2020-31/05/2023 in Srinagarind hospital 2. Age more than 18 years old 3. Hb < 12 g/dL 4. met criteria of inrondeficiency anemia
Exclusion criteria
Exclusion criteria: 1. Anemia due to bone marrow disease 2. Ferritin > 800 ng/ml 3. Transferring saturation equal or greater than 50% 4. Incomplete information
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood transfusion rate at the time of complete chemotherapy course Number of blood transfusion per chemotherapy course | — |
Secondary
| Measure | Time frame |
|---|---|
| maintaing hemoglobin within 0.5 mg/dL of basline at the time of complete chemotherapy course Hemoglobin level | — |
Countries
Thailand
Contacts
Public ContactKanynat Karasaard
Faculty of Medicine, KhonKaen University
Outcome results
None listed